Compare INKT & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INKT | TCBS |
|---|---|---|
| Founded | 2017 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.7M | 47.7M |
| IPO Year | 2021 | N/A |
| Metric | INKT | TCBS |
|---|---|---|
| Price | $12.04 | $17.60 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 19.7K | 3.3K |
| Earning Date | 11-14-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 1.14% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | ★ $15,268,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.29 |
| Revenue Growth | N/A | ★ 54.88 |
| 52 Week Low | $4.56 | $15.00 |
| 52 Week High | $76.00 | $20.00 |
| Indicator | INKT | TCBS |
|---|---|---|
| Relative Strength Index (RSI) | 50.94 | 60.99 |
| Support Level | $10.88 | $17.15 |
| Resistance Level | $12.31 | $20.00 |
| Average True Range (ATR) | 0.63 | 0.92 |
| MACD | 0.03 | 0.08 |
| Stochastic Oscillator | 63.04 | 43.93 |
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.